{
    "title": "FibroGen's lung disease drug fails late-stage trial, shares tank",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-12234283/FibroGens-lung-disease-treatment-fails-late-stage-trial.html",
    "date": "2023-06-26",
    "keywords": [
        "drug",
        "trial",
        "fibrogen",
        "latestage",
        "study",
        "pamrevlumab",
        "company",
        "june",
        "lung",
        "disease",
        "roxadustat",
        "monday",
        "decline",
        "measure",
        "function",
        "record",
        "low",
        "morning",
        "trading",
        "fibrosis",
        "ipf",
        "scar",
        "tissue",
        "oxygen",
        "bloodstream",
        "add",
        "series",
        "san",
        "disorder",
        "duchenne",
        "dystrophy",
        "month",
        "cost",
        "reduction",
        "effort",
        "cash",
        "runway",
        "decision",
        "goal",
        "change",
        "capacity",
        "volume",
        "air",
        "person",
        "indicator",
        "progression",
        "placebo",
        "share",
        "forum",
        "william",
        "blair",
        "analyst",
        "andy",
        "hsieh",
        "note",
        "companys",
        "direction",
        "product",
        "china",
        "japan",
        "regulator",
        "reporting",
        "raghav",
        "mahobe",
        "bengaluru",
        "editing",
        "shinjini",
        "ganguli",
        "bhattacharjee"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}